IDXX GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Idexx Laboratories Inc
Exchange: NASDAQSector: HealthcareIndustry: Diagnostics & Research
IDEXX Laboratories, Inc., is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 ® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories.
Did you know?
Net income compounded at 16.3% annually over 6 years.
Current Price
$569.55
+0.87%GoodMoat Value
$374.04
34.3% overvaluedProfile
Valuation (TTM)
Market Cap$45.48B
P/E42.93
EV$46.96B
P/B28.33
Shares Out79.85M
P/Sales10.57
Revenue$4.30B
EV/EBITDA30.66
Idexx Laboratories Inc (IDXX) Quality Analysis
IDXX Profitability
Profitability trend analysis coming soon
IDXX Growth
Growth trend analysis coming soon
IDXX Financial Health
Financial health indicators coming soon
IDXX Quality & Fundamental Analysis
Idexx Laboratories Inc (IDXX) is a Healthcare company in the Diagnostics & Research industry, listed on NASDAQ. This quality analysis page evaluates Idexx Laboratories Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Idexx Laboratories Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 24.62% and a return on equity (ROE) of 65.99%. Return on assets (ROA) stands at 31.62%.
The debt-to-equity ratio is 0.59, with a current ratio of 1.23. Operating margin is 31.60%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Idexx Laboratories Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.